Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis image

Novartis takes top honours in ISPE facility competition

November 12, 2013
Manufacturing and Production Novartis, WHO, foya, holly springs

Novartis’ cell culture facility in the US for the production of influenza vaccines has claimed the top prize in the …

News
Velcade image

NICE needs more Velcade data

November 12, 2013
Sales and Marketing NHS, NICE, Velcade, eric low

NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …

News
adrian_kilcoyne_celgene

Celgene hires new medical director

November 12, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne

Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …

Appointment
astrazeneca image

AstraZeneca ups cancer drug production at Alderley Park

November 11, 2013
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park

AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …

News
Contrave image

Sanofi to produce weight-loss drug for Orexigen

November 11, 2013
Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen

Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …

News
Shire image

Shire spends $4.2 billion on ViroPharma purchase

November 11, 2013
Sales and Marketing Cinryze, Firazyr, Shire, Viropharma

Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …

News

Cancer Research backs ‘unique’ database

November 11, 2013
Research and Development, Sales and Marketing Cancer, Database, ICR, cansar

An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …

News

Novartis sheds blood diagnostics for $1.7 billion

November 11, 2013
Sales and Marketing Genoptix, Novartis, blood, grifols

Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …

News
Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013
Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

News

The CDF: friend and foe?

November 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …

Feature
petra_wilson

New chief executive for the International Diabetes Federation

November 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson

The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …

Appointment
BMS image

BMS abandons hep C, diabetes and neuroscience

November 11, 2013
Sales and Marketing BMS, HIV, diabetes, hep C

Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …

News
Eylea image

Bayer submits Eylea in EU for DME

November 8, 2013
Sales and Marketing Bayer, DME, EMA, Eylea, FDA

Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …

News
brilinta image

EMA questions Brilinta data

November 8, 2013
Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor

The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …

News
gerald_moller

Genticel appoints vice president



November 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …

Appointment
dna image

UK to launch DNA database

November 8, 2013
Sales and Marketing DNA, UK, crispr, genome

Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …

News

Alzheimer’s drug development ‘must speed up’

November 7, 2013
Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

News
shire image

Shire to cut UK research jobs says source

November 7, 2013
Research and Development, Sales and Marketing England, Shire, UK, cuts

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …

News
NHS image

PPRS: thumbs-down from pharma

November 7, 2013
Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP

A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …

News

Biotec Services expands with new appointments

November 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …

Appointment
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026